Unique features of breast cancer in Asian women-Breast cancer in Taiwan as an example

Journal of Steroid Biochemistry and Molecular Biology

Volumn 118, Issue 4-5, 2010, Pages 300-303

  Huang, Chiun Sheng ^a   Lin, Ching Hung ^a   Lu, Yen Shen ^a   Shen, Chen Yang ^b,c,d  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c ACADEMIA SINICA   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Breast cancer; Epidemiology; Genetic polymorphism; Genetic susceptibility; Reproductive risk factor

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CATECHOL ESTROGEN; CATECHOL METHYLTRANSFERASE; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ASIAN; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CAUCASIAN; CLINICAL FEATURE; CONFERENCE PAPER; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; PROGNOSIS; PROTEIN EXPRESSION; PUBLIC HEALTH PROBLEM; REPRODUCTION; TAIWAN; TUMOR DIFFERENTIATION; ARTICLE; BREAST TUMOR; CARCINOMA; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS;

ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CARCINOMA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, GENETIC; PROGNOSIS; TAIWAN;

EID: 77950365402     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.12.017     Document Type: Conference Paper

References (23)

1. D.M. Parkin, F. Bray, J. Ferlay, P. Pisani, Global cancer statistics 2002, CA Cancer J. Clin. 55 (2005) 74-108.
2. F. Bray, P. McCarron, D.M. Parkin, The changing global patterns of female breast cancer incidence and mortality, Breast Cancer Res. 6 (2004) 229-239.
3. D.M. Parkin, S.L. Whelan, J. Ferlay, L. Teppo, D.B. Thomas, Cancer Incidence in Five Continents, vol. VIII, IARC Scientific Publication No. 155, 2005.
4. J.D. Yager, N.E. Davidson, Estrogen carcinogenesis in breast cancer, N. Engl. J. Med. 354 (2006) 270-282.
5. M. Clemons, P. Goss, Estrogen and the risk of breast cancer, N. Engl. J. Med. 344 (2001) 276-285.
6. L. Bernstein, J.M. Yuan, R.K. Ross, M.C. Pike, R. Hanisch, R. Lobo, F. Stanczyk, Y.T. Gao, B.E. Henderson, Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies, Cancer Causes Control 1 (1990) 51-58.
7. P.S. Yang, T.L. Yang, C.L. Liu, C.W.Wu, C.Y. Shen, A case-control study of breast cancer in Taiwan-a low-incidence area, Br. J. Cancer 75 (1997) 752-756.
8. Y.M. Song, J. Sung, M. Ha, Obesity and risk of cancer in postmenopausal Korean women, J. Clin. Oncol. 26 (2008) 3395-3402.
9. K.Y. Yoo, K. Tajima, S. Miura, T. Takeuchi, K. Hirose, H. Risch, R. Dubrow, Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case-control analysis, Am. J. Epidemiol. 146 (1997) 307-314.
10. Y.L. Lo, J.C. Yu, C.S. Huang, S.L. Tseng, T.M. Chang, K.J. Chang, C.W.Wu, C.Y. Shen, Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset), Int. J. Cancer 79 (1998) 580-587.
11. Y.C. Shen, C.J. Chang, C. Hsu, C.C. Cheng, C.F. Chiu, A.L. Cheng, Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: implications from age-period-cohort analysis, Cancer Epidemiol. Biomarkers Prev. 14 (2005) 1986-1990.
12. D.M. Parkin, P. Pisani, J. Ferlay, Estimates of the worldwide incidence of eighteen major cancers in 1985, Int. J. Cancer 54 (1993) 594-606.
13. P.D. Pharoah, A. Antoniou, M. Bobrow, R.L. Zimmern, D.F. Easton, B.A. Ponder, Polygenic susceptibility to breast cancer and implications for prevention, Nat. Genet. 3 (2002) 33-36.
14. L.M. Dong, J.D. Potter, E. White, C.M. Ulrich, L.R. Cardon, U. Peters, Genetic susceptibility to cancer: the role of polymorphisms in candidate genes, JAMA 299 (2008) 2423-2436.
15. E.L. Goode, C.M. Ulrich, J.D. Potter, Polymorphisms in DNA repair genes and associations with cancer risk, Cancer Epidemiol. Biomarkers Prev. 11 (2002) 1513-1530.
16. H.M. Lachman, D.F. Papolos, T. Saito, Y.M. Yu, C.L. Szumlanski, R.M. Weinshilboum, Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders, Pharmacogenetics 6 (1996) 243-250.
17. C.S. Huang, H.D. Chern, K.J. Chang, C.W. Cheng, S.M. Hsu, C.Y. Shen, Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility, Cancer Res. 59 (1999) 4870-4875.
18. T.C. Cheng, S.T. Chen, C.S. Huang, Y.P. Fu, J.C. Yu, C.W. Cheng, P.E. Wu, C.Y. Shen, Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: amultigenic study on cancer susceptibility, Int. J. Cancer 113 (2005) 345-353.
19. D.F. Eastone, et al., Genome-wide association study identifies novel breast cancer susceptibility loci, Nature 447 (2007) 1087-1093.
20. H.C. Yang, C.H. Lin, C.L. Hsu, S.I. Hung, J.Y. Wu,W.H. Pan, Y.T. Chen, C.S. Fann, A comparison of major histocompatibility complex SNPs in Han Chinese residing in Taiwan and Caucasians, J. Biomed. Sci. 13 (2006) 489-498.
21. S. Cleator, W. Heller, R.C. Coombes, Triple-negative breast cancer: therapeutic options, Lancet Oncol. 8 (2007) 235-244.
22. C.M. Perou, T. Sorlie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, C.A. Rees, J.R. Pollack, D.T. Ross, H. Johnsen, L.A. Akslen, O. Fluge, A. Pergamenschikov, C. Williams, S.X. Zhu, P.E. Lønning, A.L. Børresen-Dale, P.O. Brown, D. Botstein, Molecular portraits of human breast tumours, Nature 406 (2000) 747-752.
23. E.A. Rakha, J.S. Reis-Filho, I.O. Ellis, Basal-like breast cancer: a critical review, J. Clin. Oncol. 26 (2008) 2568-2581.